维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Fresta M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Drug delivery applications with ethosomes显示文摘	Ainbinder D Paolino D Fresta M		0，，：	1
2	Influence of the preparation conditions on poly(ethylcyanoacrylate) nanocapsule formation显示文摘	FRESTA M GIAMMONA G	1995	International Journal of Pharmaceutics1995，125，2：	1
3	Pefloxacine mesilate-loaded and ofloxacin-loaded polythylcyanoacrylate nanoparticles-characterization of the colloidal drug carrier formulation显示文摘	Fresta M Puglisi G Giammona G	1995	J Pharm Sci1995，84，7：	1
4	An interpretative analysis of the effect of the surfactants used for the preparation of polyalkylcyanoacrylate nanoparticles on the release process显示文摘	FRESTA M PUGLISI G	1994	J Microencapsul1994，11，5：	1
5	Pefloxacine mesilate-loaded and ofloxacin-loaded polythylcyanoacrylate nanoparticles-characterization of the colloidal drug carrier formulation显示文摘	Fresta M Puglisi G Giammona G	1995	J Pharm Sci1995，84，7：	1
6	Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs显示文摘	CAVALLARO G GIAMMONA G	1996	Biomaterials1996，17，8：	1
7	Biological effects of CDP-choline loaded long circulating liposomes on rat cerebral post-ischemic reperfusion显示文摘	Fresta M Puglisi G	1996	Int J Pharm1996，134，：	1
8	Liposomes as in vivo carriers for citicoline: Effects on rat cerebral postischaemic reperfusion 显示文摘	Fresta M Puglisi G Di Giacomo C	1994	J Pharm Pharmacol1994，46，12：	1
9	Pefloxacine mesilate-loaded and ofloxacin-loaded polyethylcyanoacrylate nanoparticles-characterization of the colloidal drug carrier formulation 显示文摘	Fresta M Puglisi G Giammona G	1995	J Pharm Sci1995，84，7：	1
10	Reduction of maturation phenomenon in cerebral ischemia with CDP-choline-loaded liposomes显示文摘	Puglisi G	1999	Pharm Res1999，16，12：	1
11	Ofloxacin- loaded liposomes : in vitro activity and drug accumulation in bacteria 显示文摘	FURNERI P M FRESTA M PUGLISI G	2000	Antimicrob Agents Chemother2000，44，9：	1
12	Entrapment of b-lactams antibiotics in polyethylcyanoacrylate nanoparticles: studies on the possible in vivo application of this colloidal delivery system显示文摘	Cavallaro G Fresta M Giammona G	1994	Int J Pharm1994，111，1：	1
13	Drug delivery applications with ethosomes 显示文摘	Ainbinder D Paolino D Fresta M	2010	J Biomed Nanotechnol2010，6，5：	1
14	International Journal ofPharmaceutics 显示文摘	Puglisi G Fresta M Giammona G	1995	125(2): 283-2871995，125，2：	1
15	Ocular tolerability and in vivo bioavailability of poly-( ethylene glycol ) ( PEG )-coated polyethyl-2-cyanoaerylate nanosphere-encapsulated aeye-lovir 显示文摘	Fresta M Fontana G Bucolo C	2001	J Pharm Sel2001，90，3：	1
16	Drug delivery applications with ethosomes显示文摘	Ainbinder D Paolino D Fresta M	2010	J Biomed Nanotechnol2010，6，5：	1
17	Preparation and characterization of polyethy-2-cyanoacrylate nanoparticles containing antiepileptic drugs显示文摘	FRESTA M CAVALLARO G GIAMMONA G	1996	Biomaterials1996，，8：	1
18	Characterization and invivo ocular absorption of liposome-encapsulated acyclovir 显示文摘	Panico AM Bucolo C	1999	JPharm Pharmacol1999，51，5：	1
19	Ofloxacin-\|oad- ed liposomes: in vitro activity and drug accumulation in baeteria 显示文摘	FURNERI PM FRESTA M PUGLISI G	2000	Antimicrob Agents Chemother2000，44，9：	1
20	Entrapment of β-lactams antibiotics in polyethylcyanoacrylate nanoparticles: studies on the possible in vivo application of this colloidal delivery system显示文摘	Cavallaro G Fresta M Giammona G	1994	Int J Pharm1994，111，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示